Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

S1 Biopharma Inc.

www.s1biopharma.com

Latest From S1 Biopharma Inc.

FDA Adds New Co-Primary Endpoint For Female Sexual Desire Drugs

Draft guidance says 'associated distress' may replace number of satisfying sexual events as a co-primary efficacy endpoint.

Clinical Trials Drug Approval Standards

Deals Shaping The Medical Industry, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2015.

BioPharmaceutical Medical Device

CKD Bolsters Chronic, Orphan Portfolio In String Of Deals

South Korea's Chong Kun Dang is diversifying its drug portfolio by licensing in several products from foreign pharma firms in a move that seems to be aimed at minimizing profit declines stemming from investment in R&D and gaining new engines of future growth.

BioPharmaceutical Asia Pacific

Biopharma In 2014: Early Access Gains Offset Taxation, Pricing Woes

The year was marked by record levels of biopharma M&A activity and a strong IPO market. Measures designed to deliver early access to new medicines continued to advance on both sides of the Atlantic, while pricing came in for renewed attention as new, highly effective but extremely expensive products reached the market.

BioPharmaceutical Pricing Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • S1 Biopharma Inc.
  • Senior Management
  • Nicolas G Sitchon, CEO
    John F Kaufmann, CFO
    Robert E Pyke, MD, PhD, CMO
  • Contact Info
  • S1 Biopharma Inc.
    Phone: (201) 839-0941
    7 WTC Ctr., 250 Greenwich St.
    46th Fl.
    New York, NY 10007
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register